secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATAI Life Sciences N.V. (—)
CIK:        0001840904
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0001140361-25-001894
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Michael Auerbach resigns from atai Life Sciences board; board size reduced to 6
--------------------------------------------------------------------------------

- Michael Auerbach resigned from the Supervisory Board and its compensation committee effective Jan 19, 2025.
- Resignation not due to any disagreement with the company on operations, policies, or practices.
- Supervisory Board size decreased from seven to six directors following his departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840904/000114036125001894/0001140361-25-001894-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840904/000114036125001894/ef20042036_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-001894

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer